Acting FDA Head Von Eschenbach Takes A Step Back At NCI
This article was originally published in The Tan Sheet
Executive Summary
FDA Acting Commissioner Andrew von Eschenbach's decision to step away from day-to-day management duties at the National Cancer Institute follows a week of criticism from Capitol Hill related to his dual role